191. Werner syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 3 / Drugs : 4 - (DrugBank : 3) / Drug target gene : 0 - Drug target pathway : 0
Werner syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 191 | Werner syndrome |
| 13 | Multiple sclerosis/Neuromyelitis optica |
| 193 | Prader-Willi syndrome |
| 299 | Cystic fibrosis |
| 2 | Amyotrophic lateral sclerosis |
| 75 | Cushing disease |
| 19 | Lysosomal storage disease |
| 46 | Malignant rheumatoid arthritis |
| 65 | Primary immunodeficiency |
| 96 | Crohn disease |
| 113 | Muscular dystrophy |
| 78 | Hypopituitarism |
| 168 | Ehlers-Danlos syndrome |
| 265 | Lipodystrophy |
| 74 | Prolactin secreting pituitary adenoma |
| 276 | Achondroplasia |
| 107 | Juvenile idiopathic arthritis |
| 3 | Spinal muscular atrophy |
| 274 | Osteogenesis Imperfecta |
| 236 | Pseudohypoparathyroidism |
| 187 | Kabuki syndrome |
| 195 | Noonan syndrome |
| 76 | Pituitary gonadotropin secretion hyperthyroidism |
| 238 | Vitamin D-resistant rickets |